COMMUNIQUÉS West-GlobeNewswire

MDxHealth (R): MDxHealth Announces Lowering of 2017 Guidance
28/12/2017
HERSTAL, BELGIUM and IRVINE, CA - December 28, 2017 - MDxHealth SA (Euronext: MDXH.BR, "MDxHealth", or the "Company"), a world leader in molecular diagnostic prostate cancer testing, today announced that, based on [...]
MDxHealth (R) : MDxHealth annonce une baisse des prévisions
28/12/2017
HERSTAL, BELGIQUE et IRVINE, CA, le 28 décembre 2017 - MDxHealth SA (Euronext : MDXH.BR), un leader mondial dans le diagnostic moléculaire du cancer de la prostate, a annoncé aujourd'hui que, sur base de résultats [...]
The Ensign Group Closes on HUD-Insured Loan Portfolio
27/12/2017
MISSION VIEJO, Calif., Dec. 27, 2017 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG ), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care [...]
Digirad Announces Sale of its MDSS Service Contracts to Philips North America
27/12/2017
SUWANEE, Ga., Dec. 27, 2017 (GLOBE NEWSWIRE) -- Digirad Corporation (Nasdaq: DRAD ) (the “Company”) today announced that it has entered into a definitive purchase agreement (“the Agreement”) with Philips North America [...]
Acer Therapeutics Announces Partial Exercise of Over-allotment Option in Public Offering
27/12/2017
NEWTON, Mass., Dec. 27, 2017 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER ), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra- [...]
Emerald Health Therapeutics Awards Stock Options
27/12/2017
VICTORIA, British Columbia, Dec. 27, 2017 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics Inc. (“Emerald” or the “Company”) (TSXV:EMH) (OTCQX:EMHTF) has agreed to issue an aggregate of 2,645,000 incentive stock options [...]
Tauriga Sciences, Inc. to Diversify $25,000 of its Balance Sheet Cash into Groestlcoin and Gain Exposure to the Crypto Currency Sector
27/12/2017
NEW YORK, NY, Dec. 27, 2017 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG ) ("Tauriga" or the "Company"), engaged in building business through the development, distribution, and licensing of proprietary [...]
Ossur Hf : Transactions in relation to share buyback program
27/12/2017
Announcement from Össur hf. No. 89/2017 Reykjavík, 27 December 2017 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]
HempAmericana Provides Detailed View Toward an Exciting 2018
27/12/2017
NEW YORK, Dec. 27, 2017 (GLOBE NEWSWIRE) -- HempAmericana, Inc. (OTC:HMPQ) (the “Company”) is proud to provide a year-end shareholder update on the Company’s progress toward its key strategic objectives as 2017 winds [...]
Sharecare to Present at J.P. Morgan Healthcare Conference for Fifth Consecutive Year
27/12/2017
ATLANTA, Dec. 27, 2017 (GLOBE NEWSWIRE) -- Sharecare , the digital health company that helps people manage all their health in one place, today announced it will present at the 36th annual J.P. Morgan Healthcare [...]
Beaucoup de donneurs de sang répondent à l’appel, mais il en faut plus
27/12/2017
OTTAWA, 27 déc. 2017 (GLOBE NEWSWIRE) -- La Société canadienne du sang a observé une augmentation importante des dons de sang depuis le 18 décembre, date à laquelle elle a lancé un appel aux donneurs pour combler les 35 [...]
TOMI Environmental Solutions, Inc. Starts New Year With Inclusion in EPA Lists G, L, and M
27/12/2017
BEVERLY HILLS, Calif., Dec. 27, 2017 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global decontamination company that specializes in disinfection/decontamination sales and services, [...]
American Health Council Names Carl Roland, PharmD, MS to Industry Board
27/12/2017
NEW YORK, Dec. 27, 2017 (GLOBE NEWSWIRE) -- Carl Roland, Senior Director at Pfizer, has been selected to join the Industry Board at the American Health Council. He will be sharing his knowledge and expertise in Clinical [...]
Actinium Pharmaceuticals Provides Update on Pivotal Phase 3 Trial of Iomab-B: Independent Data Monitoring Committee Recommends SIERRA Trial Continue
27/12/2017
Actinium expects enhanced awareness of Iomab-B at ASH annual meeting and expanded site activity to enable completion of trial enrollment by end of 2018, in-line with prior forecast NEW YORK, Dec. 27, 2017 (GLOBE [...]
UPDATE -- Eloxx Pharmaceuticals Appoints Robert Ward Chairman and Chief Executive Officer
27/12/2017
Biopharmaceutical Industry Leader with Extensive Experience In Drug Development, Strategic Business Combinations and Commercialization to Lead The Company’s Strategy, Vision and Execution WALTHAM, Mass., Dec. 27, 2017 ( [...]
Eloxx Pharmaceuticals Appoints Robert Ward Chairman and Chief Executive Officer
27/12/2017
Biopharmaceutical Industry Leader with Extensive Experience In Drug Development, Strategic Business Combinations and Commercialization to Lead The Company’s Strategy, Vision and Execution WALTHAM, Mass., Dec. 27, 2017 ( [...]
Agritek Holdings, Inc. Announces $1,000,000 Capital Infusion With Institutional Investor And Eliminates First $200,000 Of Existing Toxic Convertible Debt With Final $500,000 In Convertible Debt To Be Paid By Year End.
27/12/2017
LOS ANGELES, CA, Dec. 27, 2017 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector and consultant for multiple [...]
Sarepta Therapeutics Announces Publication of Long-Term Pulmonary Function of Eteplirsen-Treated Patients Compared to Natural History of Duchenne Muscular Dystrophy in The Journal of Neuromuscular Diseases
27/12/2017
CAMBRIDGE, Mass., Dec. 27, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to [...]
Athenex Receives Promising Innovative Medicine Designation from the United Kingdom MHRA for Oraxol, An Innovative Oral Form of Paclitaxel
27/12/2017
BUFFALO, N.Y., Dec. 27, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

Pages